Sort
261,768 grants matching “gene therapy”
UC Davis Conte Center: Neuroimmune Mechanisms of Psychiatric Disorders
$3,124,965Melissa Dawn Bauman · University Of California At Davis · P50 · FY2024 · MH
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$3,124,734Robert E Donahue · National Heart, Lung, And Blood Institute · ZIC · FY2015 · HL
OPTimIzing engageMent in discovery of molecular evolution of low grade glioma (OPTIMUM)
$3,122,950Elizabeth B. Claus · Yale University · U2C · FY2021 · CA
Section on Light and Circadian Rhythms
$3,122,721Samer Hattar · National Institute Of Mental Health · ZIA · FY2025 · MH
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$3,122,113Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
UC Davis Conte Center: Neuroimmune Mechanisms of Psychiatric Disorders
$3,122,048A Kimberley McAllister · University Of California At Davis · P50 · FY2023 · MH
SPORE in Prostate Cancer
$3,122,009Baylor College Of Medicine · P50 · FY2002 · CA
TREATING COMBAT HEARING LOSS WITH ATOHL GENE THERAPY
$3,121,232Baylor College Of Medicine · · FY2010 · Department of the Army
The Wake Forest Nonhuman Primate Radiation Survivor Cohort
$3,121,082J. Mark Cline · Wake Forest University Health Sciences · U01 · FY2021 · AI
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$3,120,485Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2012 · GM
Center for Cell Circuits
$3,119,871Aviv Regev · Broad Institute, Inc. · P50 · FY2012 · HG
Childhood Absence Epilepsy Rx, PK-PD-Pharmacogenetics
$3,119,264Tracy A Glauser · Cincinnati Childrens Hosp Med Ctr · U01 · FY2007 · NS
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
$3,119,164Carl H. June · University Of Pennsylvania · P01 · FY2024 · CA
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$3,116,742Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
University of Massachusetts Center for Clinical and Translational Science
$3,116,447Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · UL1 · FY2013 · TR
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$3,114,999Anand Swaroop · National Eye Institute · ZIA · FY2020 · EY
NHGRI/DIR Bioinformatics and Scientific Programming Core
$3,113,208Andreas Baxevanis · National Human Genome Research Institute · ZIC · FY2024 · HG
Influenza and Emerging Infectious Diseases
$3,113,196Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
CANCER CENTER SUPPORT GRANT
$3,112,358Mayo Clinic Coll Of Medicine, Rochester · P30 · FY2003 · CA
Monoclonal Immunoprotectants for Select Agents Toxins (Mab-SAT)
$3,111,286Larry Zeitlin · Mapp Biopharmaceutical, Inc. · U01 · FY2012 · AI
TYK2 Fusions in Lymphoma
$3,111,184Kojo Seys Elenitoba-Johnson · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Discovery of genetic interactions in cancer
$3,110,985Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
SPORE in Lymphoma
$3,109,934Helen E Heslop · Baylor College Of Medicine · P50 · FY2025 · CA
Prostate Cancer Imaging
$3,107,627Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Procurement and Characterization of Postmortem Brain Tissue
$3,107,226Barbara Lipska · National Institute Of Mental Health · ZIC · FY2015 · MH